 treated 64
patients with EVLA of the above knee (above-knee)
GSV. Above-knee-GSV EVLA improved symptoms
regardless of persisting below-knee reﬂux; the latter,
however, was responsible for residual symptoms and a
greater need for sclerotherapy for residual varicosities.153
A systematic review in 2021 investigated the incidence
of below-knee residual reﬂux in patients who underwent
ablation